CervoMed Inc (CRVO)

2.18 -0.13 (-5.63%) USD  |  NASDAQ  |  Jan 08, 16:00
2.21 +0.03 (+1.38%) Pre-Market: 09:01
More

CervoMed SG&A Expense (Quarterly): 2.211M for Sept. 30, 2024

SG&A Expense (Quarterly) Chart

View SG&A Expense (Quarterly) for CRVO.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View SG&A Expense (Quarterly) Chart
Start Trial

Historical Data

View Historical Data
Start Trial

SG&A Expense Definition

View SG&A Expense Definition
Start Trial

SG&A expense (short for Selling, General and Administrative expense) is a line item on the income statement, though sometimes sales and marketing expenses are reported separately from general and administrative expenses.

Read full definition.

SG&A Expense (Quarterly) Range, Past 5 Years

View SG&A Expense (Quarterly) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

SG&A Expense (Quarterly) Benchmarks

View SG&A Expense (Quarterly) Benchmarks
Start Trial
Inovio Pharmaceuticals Inc 8.614M
Abbott Laboratories 2.895B
Leap Therapeutics Inc 2.94M
AIM ImmunoTech Inc 3.079M
Protalix BioTherapeutics Inc 2.595M